Raymond James Financial Services Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$56.5M Buy
674,764
+63,071
+10% +$5.29M 0.08% 245
2024
Q2
$47.1M Buy
611,693
+77,677
+15% +$5.98M 0.07% 271
2024
Q1
$36.6M Buy
534,016
+26,466
+5% +$1.81M 0.05% 327
2023
Q4
$29.3M Buy
507,550
+14,723
+3% +$851K 0.05% 370
2023
Q3
$26M Buy
492,827
+113,832
+30% +$6.01M 0.05% 372
2023
Q2
$20.5M Buy
378,995
+13,195
+4% +$714K 0.04% 463
2023
Q1
$18.3M Buy
365,800
+67,007
+22% +$3.35M 0.03% 473
2022
Q4
$13.8M Buy
298,793
+74,668
+33% +$3.45M 0.03% 542
2022
Q3
$8.68M Buy
224,125
+11,881
+6% +$460K 0.02% 682
2022
Q2
$7.91M Buy
212,244
+10,214
+5% +$381K 0.02% 725
2022
Q1
$8.95M Sell
202,030
-29,365
-13% -$1.3M 0.02% 737
2021
Q4
$9.83M Sell
231,395
-175,378
-43% -$7.45M 0.02% 692
2021
Q3
$17.7M Buy
406,773
+4,963
+1% +$215K 0.04% 482
2021
Q2
$17.2M Buy
401,810
+2,508
+0.6% +$107K 0.04% 486
2021
Q1
$15.4M Buy
399,302
+26,088
+7% +$1.01M 0.03% 468
2020
Q4
$13.4M Buy
373,214
+213,276
+133% +$7.67M 0.03% 467
2020
Q3
$6.11M Sell
159,938
-10,267
-6% -$392K 0.02% 684
2020
Q2
$5.98M Buy
170,205
+24,062
+16% +$845K 0.02% 639
2020
Q1
$4.77M Sell
146,143
-46,295
-24% -$1.51M 0.02% 555
2019
Q4
$8.7M Buy
192,438
+27,680
+17% +$1.25M 0.03% 546
2019
Q3
$6.7M Buy
164,758
+10,679
+7% +$435K 0.02% 590
2019
Q2
$6.62M Buy
154,079
+2,928
+2% +$126K 0.03% 580
2019
Q1
$5.8M Sell
151,151
-28,764
-16% -$1.1M 0.02% 593
2018
Q4
$6.36M Buy
179,915
+77,128
+75% +$2.73M 0.03% 459
2018
Q3
$3.96M Buy
102,787
+21,116
+26% +$813K 0.02% 741
2018
Q2
$2.67M Buy
81,671
+1,415
+2% +$46.3K 0.01% 874
2018
Q1
$2.19M Buy
80,256
+28,680
+56% +$784K 0.01% 890
2017
Q4
$1.28M Sell
51,576
-28,864
-36% -$716K 0.01% 1152
2017
Q3
$2.35M Buy
80,440
+35,944
+81% +$1.05M 0.02% 850
2017
Q2
$1.23M Buy
44,496
+1,178
+3% +$32.6K 0.01% 1132
2017
Q1
$1.08M Buy
43,318
+4,657
+12% +$116K 0.01% 1135
2016
Q4
$836K Sell
38,661
-10,049
-21% -$217K 0.01% 1218
2016
Q3
$1.16M Buy
48,710
+8,648
+22% +$206K 0.01% 1019
2016
Q2
$936K Buy
40,062
+5,187
+15% +$121K 0.01% 1078
2016
Q1
$656K Buy
34,875
+6,892
+25% +$130K 0.01% 1132
2015
Q4
$516K Buy
+27,983
New +$516K 0.01% 1184